• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Ionis Pharmaceuticals

Hypertension.
Posted inCardiology, Clinical Trials, In the Pipeline

Hypertension Treatment With One Shot Every Six Months

by Julia Mardi and Timur Burkhanayev April 27, 2024May 8, 2024

Zilebesiran and tonlamarsen are advanced and convenient ways to treat high blood pressure.

heart
Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism

Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol

by Julia Mardi February 27, 2024April 19, 2024

The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.

Posted inClinical Trials, Infections

Bepirovirsen: New Drug for Hepatitis B

by Tanya von Reuss November 11, 2022November 11, 2022

Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.

brain
Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases

Qalsody: New Drug for Amyotrophic Lateral Sclerosis with SOD1 Mutation

by Julia Mardi August 2, 2022April 1, 2024

Tofersen and the mixed results of treatment for the deadly neurodegenerative disease.

Posted inNeuroscience, Pharma & Biotech, Rare/Orphan Diseases

Biogen to Develop Updated Version of Spinraza

by Julia Mardi January 5, 2022September 8, 2022

Nusinersen for the treatment of spinal muscular atrophy will get a follow-up.

Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Zolgensma: Gene Therapy That Cure Spinal Muscular Atrophy. The Most Comprehensive Review

by Tanya von Reuss, Mark Gubar, Alex Avisoni and Nik Resovski April 8, 2021September 8, 2022

Novartis revealed the most expensive drug in the world. And it is amazing.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×